Rare Disease Day Around the NMD4C Community

Rare Disease Day Around the NMD4C Community

Rare Disease Day is an opportunity to bring together communities of researchers, health care providers and patients under a unified theme. As a network which serves a rare disease community, we wish to promote the NMD activities that will take place on Rare Disease Day. In 2021 there is more opportunity to attend and get involved than ever before due to the increasing frequency of remotely accessible and virtual events!

 

Here are some of the upcoming Rare Disease Day 2021 events within our network:

 

  • Jesse’s Journey will run a social media campaign throughout all February, profiling four families (one per week) for people to share and help raise awareness of Duchenne muscular dystrophy. Visit Jesse’s Journey’s website in the next weeks for more information.
  • The Canadian Organization for Rare Disease (CORD) will be encouraging the Duchenne community to attend their Conference in early March titled “From Draft to Action Plan” on March 9-10, 2021 from 11am to 2pm EST.
  • The Groupe de recherche interdisciplinaire en maladies neuromusculaires (GRIMN) will host an regional French event on February 25th 2021 called “Rare et fréquent, c’est possible!” in collaboration with the Centre intersectoriel en santé durable (CISD), the CIUSSS du Saguenay-Lac-Saint-Jean and CORAMH in which a section will focus on neuromuscular diseases. Details will be published on the GRIMN facebook page :

 

Are you organizing a Rare Disease Day webinar, a conference, a workshop or any other activity that could be of interest to other NMD4C members? Send us information about your Rare Disease Day activities to the following address: . The network will be pleased to share the various activities of Rare Disease Day with our members.

 

Together we can show how the neuromuscular community is engaging in Rare Disease Day!

 

Return to the February 2021 Newsletter

Rare Disease Day Around the NMD4C Community

Read next...

CPNG 2026

Zolgensma® Safety Update and CPNG Guidance for Families

The Canadian Pediatric Neuromuscular Group (CPNG) has issued a statement for families regarding recent reports of tumours in children treated with Zolgensma® (onasemnogene abeparvovec) gene therapy for spinal muscular atrophy (SMA). The statement outlines current evidence, considerations for follow-up care, and information for families and healthcare providers.

2026 Trainee Publication of the Year Awardee Spotlight on Jules Granet

Could You Be Our Next Awardee? Meet Jules Granet, NMD4C’s 2026 Publication of the Year Awardee

Nominations are open till by 18 January 2027!
In 2026, Jules Granet, a PhD Candidate at McGill University and trainee in Dr. Natasha Chang’s laboratory received an NMD4C Publication of the Year Award for research investigating how muscle stem cell dysfunction contributes to impaired muscle regeneration in Duchenne muscular dystrophy. Nominate yourself or a neuromuscular colleague whose research, clinical care, leadership, advocacy, or community contributions deserve to be recognized.

Save the date: 8th Ottawa International Conference On Neuromuscular Disease & Biology

Early Bird Registration Now Open: 8th Ottawa International Conference On Neuromuscular Disease & Biology

We are happy to announce that early bird registration is now open for the 8th Ottawa International Conference On Neuromuscular Disease & Biology which will be held on October 14-16, 2027 at the Fairmont Château Laurier in Ottawa, Canada. Now under the leadership of NMD4C Investigators; Dr. Mireille Khacho, Dr. Hanns Lochmuller, Dr. Bernard Jasmin, and Dr. Rashmi Kothary.